Seeing Is Believing
Healthcare - Sector
Satsuma Pharmaceuticals's activity chart (see below) currently has 18 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.33% with an average time for these price targets to be met of 92.67 days.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 18-Apr-2023. First documented stock forecast 08-Oct-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Sep-2022
$3
3 years 5 months 13 days ago
(18-Apr-2023)
0/5 (0%)
$2.29 (322.54%)
Buy
$14
3 years 10 months 14 days ago
(16-Nov-2022)
0/1 (0%)
$8.01 (133.72%)
Buy Since 15-Nov-2022
$1
$-0.1 (-9.09%)
3 years 10 months 16 days ago
(15-Nov-2022)
2/2 (100%)
$0.37 (58.73%)
62
Buy Since 16-Mar-2022
$15
4 years 4 months 18 days ago
(13-May-2022)
2/5 (40%)
$11.22 (296.83%)
192
Sell Since 11-Nov-2020
$6.5
$5.4 (490.91%)
$3.5
5 years 6 months 29 days ago
(02-Mar-2021)
4/4 (100%)
$0.25 (4.00%)
163
What is STSA (Satsuma Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on STSA (Satsuma Pharmaceuticals)?
Which analyst has the most public recommendations on STSA (Satsuma Pharmaceuticals)?
Which analyst is the currently most bullish on STSA (Satsuma Pharmaceuticals)?
Which analyst is the currently most reserved on STSA (Satsuma Pharmaceuticals)?